News
1d
Zacks Investment Research on MSNGilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should KnowGilead Sciences (GILD) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...
19h
Zacks Investment Research on MSNGilead Sciences (GILD) Reports Next Week: Wall Street Expects Earnings GrowthThe market expects Gilead Sciences (GILD) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus ...
Ipsen and its fellow French partner Genfit are competing with Intercept and Advanz’s Ocaliva, which was approved in 2016 and ...
Gilead Sciences’ sponsorship of a conference Wi-Fi network has landed it in hot water. | Gilead Sciences’ sponsorship of a ...
A group of academics is arguing that countries seeking access to a groundbreaking HIV prevention drug from Gilead Sciences ...
2d
US Weekly on MSNWhat to Know About ‘The Handmaid’s Tale’ Spinoff ‘The Testaments’: Returning Cast Members and MoreHulu's spinoff of 'The Handmaid's Tale' titled 'The Testaments' comes after the original show's sixth and final season ...
Wesley Sundquist, a biochemist at University of Utah, and Tomas Cihlar, a virologist at Gilead, a biopharmaceutical company, ...
3d
Dexerto on MSNWhat is a Martha? The Handmaid’s Tale social rankings explainedWith The Handmaid’s Tale Season 6 airing now, here’s what you need to know about Marthas and the social hierarchy for women ...
"It's not about a relationship she chose, like with Fred," Bruce Miller says, explaining why writers chose to introduce the ...
As the final season of "The Handmaid's Tale" begins today, we're taking a look back on everything to know about the hit Hulu ...
Research in the Sundquist lab laid the foundations for the development of lenacapavir, a drug that prevents HIV infection ...
The resistance against Gilead carries on. Here's what you need to remember before "The Handmaid's Tale" Season 6 starts.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results